Schedule 13G ownership disclosure
Ritter Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 767836109
Event date: 2016-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.8800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-131726
- Form type
- SC 13G
- Filer
- Knoll Capital Management, LLC
- CIK
- CIK 1325083
- Filed
- Nov 04, 2016
- Reporting period
- Oct 31, 2016
- Description
- Schedule 13G beneficial ownership